Loading…
Sunday, June 24 • 1:00pm - 4:30pm
#31: Machine Learning in Pharmacovigilance

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Tutorial
CE: ACPE 3.25 Knowledge UAN: 0286-0000-18-508-L04-P; CME 3.25; IACET 3.25; RN 3.25

This short course will explore machine learning (ML) and its application within the Regulatory/ Pharmacovigilance (PV) landscape. We will provide a high-level introduction to ML, including tools and project tips. The core of the course will dive deeper into applications within PV, including examples from our work on ICSR identification. We will also discuss what the future of ML in PV could look like, followed by time for questions and open discussion.

Since machine learning requires resources from across the organization, this course is designed for anyone interested in sponsoring or joining a machine learning project within their organization.
An additional registration fee is required for all preconference short courses.
Back to DIA 2018 Short Courses  

Who should attend?

This short course is designed for members of Pharma, Academia, Regulators, and Medicine interested in Machine Learning in PV

Learning Objectives

At the conclusion of this course, participants should be able to:
  • Identify advances that make ML practical
  • Describe how ML can be applied to the regulatory and PV landscape
  • Develop potential future use cases for ML in PV



Speakers
avatar for Robert Ball

Robert Ball

Deputy Director, Office of Surveillance and Epidemiology, CDER, FDA
Robert Ball MD, MPH, ScM is Deputy Director, Office of Surveillance and Epidemiology (OSE), Center for Drug Evaluation and Research (CDER), FDA. Dr. Ball shares in the responsibilities for leading OSE staff evaluating drug risks and promoting the safe use of drugs by the American... Read More →
avatar for Shaun Comfort

Shaun Comfort

Associate Director and Senior Safety Science Leader IIDO, Genentech, A Member of the Roche Group
Dr. Comfort is Associate Director for Risk Management and Sr. Safety Science Leader for Roche-GNE Late Stage Ophthalmology/Hematology Products. He is a Board Certified Neurologist with 13 years combined industry experience including roles as former Medical Reviewer at the US FDA and... Read More →
avatar for Bruce Donzanti

Bruce Donzanti

Senior Group Director, Global Pharmacovigilance Innovation Policy, Genentech, A Member of the Roche Group
Bruce has a PhD in pharmacology/neuroscience with almost 30 years of experience in the pharma/biotech industry. Prior to industry, he performed research on mechanisms of neuronal degeneration and neurotoxicology and lectured in neuropharmacology to graduate and medical students while... Read More →
avatar for Mick Foy

Mick Foy

Head of Pharmacovigilance Strategy, Vigilance Intelligence, and Research Group, Medicines and Healthcare Products Regulatory Agency (MHRA)
Mick Foy is Head of Pharmacovigilance Strategy at the MHRA. Among is responsibilities is the running of the UK ADR reporting system and signal detection activities. Mick is also leads the MHRA's work with WHO and the Bill and Melinda Gates Foundation on capacity building in low and... Read More →


Sunday June 24, 2018 1:00pm - 4:30pm
Room 160B Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA